Jujuboside B

The strongest jujuboside-B-specific CNS signal: in mice it suppressed febrile seizures by dampening AMPA-receptor glutamatergic activity ^{3Reference 32023Jujuboside B inhibits febrile seizure by modulating AMPA-receptor activityView study →}, and in C. elegans it protected against amyloid-β toxicity via daf-16/sir-2.1 (FOXO/sirtuin) pathways ^{2Reference 2Liu Y et al. · 2026Metabolomic insights into the neuroprotective actions of Ziziphi Spinosae Semen and jujuboside B against Aβ-induced toxicityView study →} — a plausible mechanistic bridge to suan zao ren’s sedative rationale (reduced neuronal excitability).

Gap: two small preclinical studies in different models (mouse seizure, worm), with no sleep/EEG or anxiolytic endpoint for the isolate, no mammalian neurodegeneration model and no human data ^{2,3Reference 2Liu Y et al. · 2026Metabolomic insights into the neuroprotective actions of Ziziphi Spinosae Semen and jujuboside B against Aβ-induced toxicityView study →Reference 32023Jujuboside B inhibits febrile seizure by modulating AMPA-receptor activityView study →}.

In a rodent sepsis model, jujuboside B lowered ALT/AST and reduced TNF-α, IL-1β and NO in septic liver injury ^{1Reference 1Kim SJ et al. · 2023Hepatoprotective functions of jujuboside BView study →}.

Gap: a single study in one model, with no dose-ranging and no chronic/fibrosis or human liver data — an anti-inflammatory rather than metabolic-liver effect ^{1Reference 1Kim SJ et al. · 2023Hepatoprotective functions of jujuboside BView study →}.

Jujuboside B inhibited HMGB1-mediated severe inflammatory responses in human endothelial cells and mice ^{4Reference 42023AnimalJujuboside B inhibited HMGB1-mediated severe inflammatory responses in human endothelial cells and miceView study →} — mechanistically consistent with the sepsis hepatoprotection (shared late-inflammatory axis).

Gap: a single cell+mouse study with surrogate inflammatory endpoints and no clinical translation ^{4Reference 42023AnimalJujuboside B inhibited HMGB1-mediated severe inflammatory responses in human endothelial cells and miceView study →}.

Ziziphus jujuba and its component jujuboside B inhibit platelet aggregation ^{5Reference 52013Zizyphus jujuba and its active component jujuboside B inhibit platelet aggregationView study →}, and jujuboside B inhibited neointimal hyperplasia and vascular-smooth-muscle-cell dedifferentiation via AMPK/PPAR-γ ^{6Reference 62021Jujuboside B inhibits neointimal hyperplasia and prevents VSMC dedifferentiation, proliferation and migration via AMPK/PPAR-γView study →}.

Gap: in-vitro and rodent only; the antiplatelet effect implies a theoretical bleeding/anticoagulant-interaction caution but is unquantified in humans ^{5,6Reference 52013Zizyphus jujuba and its active component jujuboside B inhibit platelet aggregationView study →Reference 62021Jujuboside B inhibits neointimal hyperplasia and prevents VSMC dedifferentiation, proliferation and migration via AMPK/PPAR-γView study →}.

Suan zao ren whole seed/extract has a genuine traditional and clinical sedative use — but the studied actives and quality markers are jujuboside A and spinosin, not jujuboside B ^{7,8Reference 7Liu Z et al. · 2024ReviewPhytochemical, pharmacological, pharmacokinetic and toxicological characteristics of Ziziphi Spinosae Semen: a reviewView study →Reference 8Shergis JL et al. · 2020ReviewZiziphi Spinosae Semen: a review of botanical uses, phytochemistry, pharmacology, pharmacokinetics and toxicologyView study →}.

Gap: there is no jujuboside-B monotherapy sleep, EEG or anxiolytic study, so the clinical hypnotic effect must not be attributed to this isolate — its contribution is inferred from class membership and the AMPA finding above ^{7Reference 7Liu Z et al. · 2024ReviewPhytochemical, pharmacological, pharmacokinetic and toxicological characteristics of Ziziphi Spinosae Semen: a reviewView study →}.